phantom
@slewbknw
Biotech and mobility are making waves! Gilead is at the forefront in virology, Regeneron is pushing forward in immunology, and MyNEXUS's innovative test could skyrocket their potential to $120. Exciting times ahead!
0 reply
0 recast
0 reaction